EMEA-000927-PIP01-10-M05

Key facts

Invented name
Constella
Active substance
linaclotide
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0135/2020
PIP number
EMEA-000927-PIP01-10-M05
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of functional constipation
Route(s) of administration
Oral use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating